| RS1085307794 |
CHD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS1085307795 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS1085307796 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1085307797 |
TAFAZZIN
|
Health Risk |
Pathogenic/Likely pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS1085307800 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS1085307802 |
TYMP
|
Health Risk |
Pathogenic |
— |
| RS1085307804 |
SLC6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1085307806 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, TULP1-related disorder |
| RS1085307808 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1085307810 |
CAD
|
Health Risk |
Pathogenic |
— |
| RS1085307811 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1085307816 |
COL4A1
|
Health Risk |
Pathogenic |
Uterine corpus endometrial carcinoma, Uterine corpus endometrial carcinoma |
| RS1085307818 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1085307819 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1085307823 |
VPS13A
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS1085307825 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1085307826 |
PURA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1085307830 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1085307831 |
HNRNPK
|
Health Risk |
Pathogenic |
— |
| RS1085307837 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1085307838 |
CNTNAP2
|
Health Risk |
Likely pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1085307841 |
FGD1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307843 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS1085307845 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1085307849 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1085307851 |
DCX
|
Health Risk |
Pathogenic |
— |
| RS1085307853 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1085307855 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1085307857 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1085307859 |
MBD5
|
Health Risk |
Pathogenic |
— |
| RS1085307870 |
NONO
|
Health Risk |
Pathogenic |
— |
| RS1085307871 |
SYNGAP1
|
Health Risk |
Pathogenic |
— |
| RS1085307872 |
ACVRL1
|
Health Risk |
Pathogenic |
— |
| RS1085307873 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1085307874 |
SPG7
|
Health Risk |
Pathogenic |
— |
| RS1085307875 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1085307876 |
GNAO1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with involuntary movements, Developmental and epileptic encephalopathy |
| RS1085307877 |
EXT2
|
Health Risk |
Pathogenic |
— |
| RS1085307879 |
FGFR1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307880 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1085307883 |
IKBKG
|
Health Risk |
Pathogenic |
— |
| RS1085307884 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS1085307885 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1085307886 |
FAT4
|
Health Risk |
Likely pathogenic |
— |
| RS1085307887 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307888 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1085307889 |
TNNT2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307891 |
PTEN
|
Health Risk |
Pathogenic |
— |
| RS1085307892 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307893 |
LOC102724058;SCN1A;SCN1A-AS1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Generalized epilepsy with febrile seizures plus |
| RS1085307894 |
GNAO1
|
Health Risk |
Pathogenic |
— |
| RS1085307895 |
ARSL
|
Health Risk |
Likely pathogenic |
— |
| RS1085307896 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1085307897 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1085307898 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1085307899 |
SRCAP
|
Health Risk |
Pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS1085307900 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1085307901 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1085307902 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1085307903 |
NSD1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307904 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307905 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1085307906 |
NPR2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307907 |
COL4A1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307908 |
ATP2A2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307909 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307910 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS1085307911 |
EP300
|
Health Risk |
Likely pathogenic |
— |
| RS1085307913 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young |
| RS1085307914 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS1085307915 |
SPTBN2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307916 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1085307917 |
B3GAT3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307918 |
PYGM
|
Health Risk |
Likely pathogenic |
— |
| RS1085307919 |
DCX
|
Health Risk |
Likely pathogenic |
— |
| RS1085307920 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1085307921 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1085307923 |
ARID1A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307924 |
SMARCE1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307925 |
DHCR7
|
Health Risk |
Likely pathogenic |
— |
| RS1085307926 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1085307927 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS1085307928 |
TRMU
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS1085307929 |
MMUT
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1085307930 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1085307931 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307932 |
GNAO1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307933 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1085307934 |
CDKL5
|
Health Risk |
Likely pathogenic |
— |
| RS1085307935 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1085307936 |
IDH2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307937 |
TWNK
|
Health Risk |
Likely pathogenic |
— |
| RS1085307938 |
CLCN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hyperaldosteronism type II, Familial hyperaldosteronism type II |
| RS1085307939 |
POLR3A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307940 |
SCN8A
|
Health Risk |
Pathogenic |
— |
| RS1085307941 |
MED12
|
Health Risk |
Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, MKB type |
| RS1085307942 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307943 |
KCNH2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307944 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile liver failure syndrome 2, Infantile liver failure syndrome 2 |
| RS1085307945 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |